Novo Nordisk to Acquire Corvidia Therapeutics
- June 12, 2020
Novo Nordisk A/S announced June 11 a definitive agreement to acquire Corvidia Therapeutics Inc. in a deal valued at up to $2.1 billion
ARTICLE TAGS
You must be logged in to access this content.